Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

AKYA Akoya BioSciences Inc

2,49

-0,06 (-2,35%)

20 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Akoya BioSciences Charts.

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Akoya BioSciences Charts.

News Akoya BioSciences Inc

Form 8-K - Current report
Freitag 13 Dezember 2024 (1 Woche vor) • Edgar (US Regulatory)

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
Dienstag 10 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
Montag 9 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Akoya Biosciences Reports Third Quarter 2024 Financial Results
Donnerstag 14 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
Dienstag 5 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Montag 4 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Akoya BioSciences Inc News-Artikel

Financial Select Sector

Deutsche Lufthansa

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen